The UK government on Friday authorised the Moderna CCP virus vaccine, which became the third vaccine to be approved after the Pfizer/BioNTech and the Oxford/AstraZeneca jabs.
Regulatory approval was granted by the UK’s medicines regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).
“Once in use, all COVID-19 vaccines are continually monitored by the MHRA. This ensures that the benefits in protecting people against COVID-19 continue to far outweigh any potential side-effects,” she said.
She emphasised that it is “vital” that everyone follows the national lockdown restrictions, even if they have had a vaccine.
The Dutch national drugs authority, the CBG, said the Moderna vaccine was expected to be effective against the variant of the CCP virus detected in Britain, but cautioned this had to be confirmed by further research.
It has to be stored and shipped frozen, but does not require the ultra-cold temperatures of the Pfizer/BioNTech vaccine. Once thawed, it can be kept at typical refrigerator temperatures.
The UK was also the first country to authorise the Oxford/AstraZeneca jab, which began to be deployed in the country on Monday. The government has ordered 100 million doses of the vaccine—enough to potentially inoculate the whole country.